Technique and Short-Term Outcome of Green Light Laser (KTP, 80 W) Vaporisation of the Prostate

European Urology

Volumn 52, Issue 6, 2007, Pages 1632-1637

  Heinrich, Elmar ^a   Schiefelbein, Frank ^a   Schoen, Georg ^a  

^a Missionsarztliche Klinik Wurzburg   (Germany)

Author keywords

BPH; KTP; Laser surgery; Prostate; Prostatic hyperplasia; Vaporisation

Indexed keywords

POTASSIUM; PROSTATE SPECIFIC ANTIGEN; TITANIUM DERIVATIVE;

ADULT; AGED; ARTICLE; BLADDER CATHETERIZATION; DYSURIA; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; LASER SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; ORGAN SIZE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; RESIDUAL URINE; TRANSURETHRAL RESECTION; VAPORIZATION;

AGED; AGED, 80 AND OVER; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PHOSPHATES; PROSTATECTOMY; PROSTATIC HYPERPLASIA; TITANIUM; TREATMENT OUTCOME; VOLATILIZATION;

EID: 35748930216     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.07.033     Document Type: Article

References (24)

1. Berry S.J., Coffey D.S., Walsh P.C., and Ewing L.L. The development of human benign prostatic hyperplasia with age. J Urol 132 (1984) 474-479
2. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Diagnosis and treatment recommendations. J Urol 2003;170:530-47.
3. Schulman C.C., Zlotta A.R., Rasor J.S., Hourriez L., Noel J.C., and Edwards S.D. Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 24 (1993) 415-423
4. Kabalin J.N., Bite G., and Doll S. Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients. J Urol 155 (1996) 181-185
5. Blute M.L., Tomera K.M., Hellerstein D.K., et al. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. J Urol 150 (1993) 1591-1596
6. Muschter R., and Hofstetter A. Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol 9 (1995) 129-135
7. van Melick H.H., van Venrooij G.E., and Boon T.A. Laser prostatectomy in patients on anticoagulant therapy or with bleeding disorders. J Urol 170 (2003) 1851-1855
8. Watterson J.D., Girvan A.R., Cook A.J., et al. Safety and efficacy of holmium:YAG laser lithotripsy in patients with bleeding diatheses. J Urol 168 (2002) 442-445
9. Kuntz R.M. Laser treatment of benign prostatic hyperplasia. World J Urol 25 (2007) 241-247
10. Elzayat E.A., and Elhilali M.M. Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol. 52 (2007) 1465-1472
11. Te A.E., Malloy T.R., Stein B.S., et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172 (2004) 1404-1408
12. Bachmann A., Reich O., Wyler S., et al. The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures. Urologe A 43 (2004) 1262-1270
13. Kumar S.M. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 173 (2005) 511-513
14. Rassweiler J., Teber D., Kuntz R., and Hofmann R. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50 (2006) 969-980 (discussion 980)
15. Malek R.S., and Nahen K. Photoselective vaporization of the prostate: KTP laser therapy of obstructive benign prostatic hyperplasia. AUA Update Service 2004 (2004) 153-159
16. Kuntzman R.S., Malek R.S., Barrett D.M., and Bostwick D.G. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 49 (1997) 703-708
17. Kuntzman R.S., Malek R.S., Barrett D.M., and Bostwick D.G. Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 48 (1996) 575-583
18. Hai M.A., and Malek R.S. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 17 (2003) 93-96
19. Malek R.S., Kuntzman R.S., and Barrett D.M. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 163 (2000) 1730-1733
20. Bouchier-Hayes D.M., Anderson P., Van Appledorn S., Bugeja P., and Costello A.J. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 20 (2006) 580-585
21. Ruszat R., Wyler S., Forster T., et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51 (2007) 1031-1041 (discussion 1038-41)
22. Ahyai S.A., Lehrich K., and Kuntz R.M. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. 52 (2007) 1456-1464
23. Shah H.N., Mahajan A.P., Hegde S.S., and Bansal M.B. Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int 100 (2007) 94-101
24. Volkan T., Ihsan T.A., Yilmaz O., et al. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 48 (2005) 608-613